Skip to main content
. 2022 Mar 2;23(5):2766. doi: 10.3390/ijms23052766

Figure 11.

Figure 11

(A) General structure of compounds 8.868.147. (B) Design principle and key compounds in the programme with some of their pharmacological properties. In red and blue marked are fragments subject to hybridization.